Journal of Cardiac Failure
Volume 13, Issue 6 , Pages 445-451 , August 2007

Multiparametric Risk Stratification in Patients With Mild to Moderate Chronic Heart Failure

  • Angela Beatrice Scardovi, MD

      Affiliations

    • From the Department of Cardiology, S. Spirito Hospital, Rome, Italy
    • Corresponding Author InformationReprint requests: Dott. Angela Beatrice Scardovi, Cardiology Department, S. Spirito Hospital, Lungotevere in Sassia 1, 00143 Rome, Italy.
    • ,
  • Renata de Maria, MD

      Affiliations

    • CNR Clinical Phisiology Institute, Milan, Italy
    • ,
  • Claudio Coletta, MD

      Affiliations

    • From the Department of Cardiology, S. Spirito Hospital, Rome, Italy
    • ,
  • Nadia Aspromonte, MD

      Affiliations

    • From the Department of Cardiology, S. Spirito Hospital, Rome, Italy
    • ,
  • Silvia Perna, MD

      Affiliations

    • Department of Cardiology, S. Andrea Hospital, University of Medicine “La Sapienza”, Rome, Italy
    • ,
  • Giuseppe Cacciatore, MD

      Affiliations

    • Department of Cardiology San Giovanni – Addolorata Hospital, Rome, Italy
    • ,
  • Marina Parolini, MD

      Affiliations

    • CNR Clinical Phisiology Institute, Milan, Italy
    • ,
  • Roberto Ricci, MD

      Affiliations

    • From the Department of Cardiology, S. Spirito Hospital, Rome, Italy
    • ,
  • Vincenzo Ceci, MD

      Affiliations

    • From the Department of Cardiology, S. Spirito Hospital, Rome, Italy

Received 21 October 2006 ,Revised 5 February 2007 ,Accepted 6 March 2007.

References 

  1. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J. 2005;26:1115–1140
  2. De Silva R, Rigby AS, Witte KK, Nikintin NP, Tin L, Goode K, et al. Anemia, renal dysfunction and their interactions in patients with chronic heart failure. Am J Cardiol. 2006;98:391–398
  3. Anand IS, Kuskowski MA, Rector TS, Florea VG, Glazer RD, et al. for the Val-HeFT Investigators Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure. Results from Val-HeFT Circulation. 2005;112:1121–1127
  4. Working Group on Cardiac Rehabilitation and Exercise Physiology and Working Group on Heart Failure of European Society of Cardiology . Recommendations for exercise testing in chronic heart failure patients. Eur Heart J. 2001;22:37–45
  5. Opasich C, Pinna GD, Bobbio M, Sisti M, Demichelis B, Febo O, et al. Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient. J Am Coll Cardiol. 1998;3:766–775
  6. Kao W, Winkel EM, Johnson MR, Piccione W, Lichtenberg R, Costanzo MR. Role of maximal oxygen consumption in establishment of heart transplant candidacy for heart failure patients with intermediate exercise tolerance. Am J Cardiol. 1997;79:1124–1127
  7. Corra U, Mezzani A, Bosimini E, Scapellato F, Imparato A, Giannuzzi P. Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. Am Heart J. 2002;143:418–426
  8. Ponikowski P, Francis DP, Piepoli MF, Davies LC, Chua TP, Davos CH, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance. Marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation. 2001;103:967–972
  9. Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA. Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J. 2004;147:354–360
  10. Arena B, Humphrey R. Relationship between ventilatory expired gas and cardiac parameters during symptom- limited exercise testing in patients with heart failure. J Cardiopulm Rehabil. 2001;21:130–134
  11. Silver MA, Maisel A, Yancy CW, McCullough PA, Burnett JC, Francis GS, et al. BNP consensus panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail. 2004;10(Suppl 3):S1–S30
  12. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B- type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ. 2005;330:625
  13. Isnard R, Pousset F, Chafirovskaia O, Carayon A, Hulot JS, Thomas D, et al. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure. Am Heart J. 2003;146:729–735
  14. de Groote P, Dagorn JI, Soudan B, Lamblin N, McFadden E, Bauters C. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol. 2004;43:1584–1589
  15. Thohan V. Prognostic implications of echocardiography in advanced heart failure. Curr Opin Cardiol. 2004;19:238–249
  16. Bruch C, Gotzmann M, Stypmann J, et al. Electrocardiography and Doppler echocardiography for risk stratification in patients with chronic heart failure. Incremental prognostic value of QRS duration and a restrictive mitral filling pattern. J Am Coll Cardiol. 2005;45:1072–1075
  17. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron1976;16:31–41.
  18. Wasserman K, Hansen JE, Sue DY, Whipp BJ. Principles of exercise testing and interpretation. Philadelphia: Lea & Febiger; 1986;
  19. Cohen-Solal A, Zannad F, Kayanakis JG, Gueret P, Aupetit JF, Kolsky H. Multicentre study of the determination of peak oxygen uptake and ventilatory threshold during bicycle in chronic heart failure. Eur Heart J. 1991;12:1055–1063
  20. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–367
  21. Maisel AS, Koon J, Krishnaswamy P, Kazenegra R, Clopton P, Gardetto N, et al. Utility of B-natriuretic peptide as a rapid, point–of–care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 2001;141:367–374
  22. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A, et al. Plasma B- type natriuretic peptide levels in systolic heart failure. J Am Coll Cardiol. 2004;43:416–422
  23. Kruger S, Graf J, Kunz D, Stickel T, Hanrath P, Janssens U. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol. 2002;40:718–722
  24. Scardovi AB, De Maria R, Coletta C, Aspromonte N, Perna S, Infusino T, et al. Brain natriuretic peptide is a reliable indicator of ventilatory abnormalities during cardiopulmonary exercise test in heart failure patients. Med Sci Monit. 2006;12:CR191–CR195
  25. Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 2001;37:386–391
  26. Scardovi AB, Coletta C, Aspromonte N, Perna S, Greggi M, D'Errigo P, et al. Brain natriuretic peptide plasma level is a reliable indicator of advanced diastolic dysfunction in patients with chronic heart failure. Eur J Echocardiogr. 2007;8:30–36
  27. Bettencourt P. NT-pro BNP and BNP: biomarkers for heart failure management. Eur J Heart Fail. 2004;6:359–363
  28. Chua TP, Clark AL, Amadi AA, Coats AJ. The relationship between chemosensitivity and ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol. 1996;27:650–657
  29. Piepoli M, Clark AL, Volterrani M, Adamopoulos S, Sleight P, Coats AJ. Contribution of muscle afferents to the hemodynamic, autonomic and ventilatory responses to exercise in patients with chronic heart failure. Circulation. 1996;93:940–952
  30. Metra M, Dei Cas L, Panina G, Visioli O. Exercise hyperventilation chronic congestive heart failure and its relation to functional capacity and hemodynamics. Am J Cardiol. 1992;70:622–628
  31. Hansen A, Haass M, Zugck C, et al. Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol. 2001;37:1049–1055
  32. Haug C, Metzele A, Steffgen J, Kochs M, Hombach V, Grunert A. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. J Clin Invest. 1994;72:430–434

PII: S1071-9164(07)00075-9

doi: 10.1016/j.cardfail.2007.03.003

Journal of Cardiac Failure
Volume 13, Issue 6 , Pages 445-451 , August 2007

Article Tools

* Image Usage & Resolution